PRESS RELEASE published on 01/22/2024 at 09:00, 1 year 10 months ago GANÉ Aktiengesellschaft: Dr Uwe Rathausky and J. Henrik Muhle named Fund Manager of the Year 2024 GANÉ Aktiengesellschaft's Directors and Fund Advisors, Dr Uwe Rathausky and J. Henrik Muhle, have been honored with the 'Fund Manager of the Year 2024' award by Finanzen Verlag for their exceptional performance. The award recognizes their successful management of the GANÉ Global Equity Fund and ACATIS GANÉ Value Event Fund, underpinned by their unique value and event investment strategy. This achievement reflects their dedication to delivering excellent results for investors and their commitment to long-term success in the market. For more information, visit www.gane.de. GANÉ Aktiengesellschaft Dr Uwe Rathausky J. Henrik Muhle Fund Manager Of The Year Value Investment
PRESS RELEASE published on 01/22/2024 at 09:00, 1 year 10 months ago ANDRITZ holds Capital Markets Day on January 24 ANDRITZ, an international technology group, will hold its 2024 Capital Markets Day on January 24 in Leipzig, Germany. The event will provide updates on the group’s businesses, markets, strategy, and growth drivers, and will be available on the group’s website. ANDRITZ offers innovative solutions for various industries and end markets and aims to contribute to a sustainable future. With a global presence and a focus on long-term profitable growth, ANDRITZ is a market leader in Pulp & Paper, Metals, Hydropower, and Environment & Energy. Sustainable Solutions ANDRITZ Capital Markets Day Technology Group Business Strategy Global Market Leader
PRESS RELEASE published on 01/22/2024 at 08:30, 1 year 10 months ago Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months Abivax, a clinical-stage biotechnology company, provides its 2024 strategic outlook and key milestones, including the expected data read-outs and trial results for its lead drug candidate obefazimod in the treatment of ulcerative colitis and Crohn’s disease. The company also outlines its financial update and objectives for strengthening its product pipeline. Learn more about Abivax's priorities and milestones for 2024. Abivax Obefazimod Ulcerative Colitis Crohn’s Disease Clinical Trials
PRESS RELEASE published on 01/22/2024 at 08:30, 1 year 10 months ago Abivax: Perspectives stratégiques d’Abivax pour 2024 et principales étapes au cours des 12 prochains mois Abivax annonce ses perspectives stratégiques pour 2024 et les principales étapes des 12 prochains mois, y compris la publication des premiers résultats des essais d'induction du programme pivot ABTECT de phase 3 Abivax Obefazimod Stratégique Perspectives Étapes Clés
PRESS RELEASE published on 01/22/2024 at 08:00, 1 year 10 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announced the purchase of 105,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange, as part of its share buyback program. The repurchased shares will be cancelled, and the company's total number of ordinary shares after settlement and cancellation will be 653,285,633. The detailed breakdown of individual trades made as part of the share buyback program is also provided in the announcement. London Stock Exchange Ordinary Shares Share Buyback Program Cairn Homes Plc Euronext Dublin
PRESS RELEASE published on 01/22/2024 at 08:00, 1 year 10 months ago Custodian Property Income REIT plc: Custodian Property Income REIT sells industrial unit at 9.5% premium to valuation Custodian Property Income REIT plc (CREI) announces the sale of an industrial unit in Milton Keynes at a 9.5% premium to valuation, representing a significant profit for shareholders. The sale proceeds will be used to reduce the company's existing debt facility and fund future portfolio improvements. Real Estate Investment Trust Custodian Property Income REIT Plc Industrial Unit Sale Premium To Valuation Portfolio Improvements
PRESS RELEASE published on 01/22/2024 at 08:00, 1 year 10 months ago Update on the Scheme and Resignation of Directors Arix Bioscience PLC provides an update on the recommended all-share acquisition of Arix's assets by RTW Biotech Opportunities Ltd, including the resignation of directors Maureen O'Connell and Isaac Kohlberg. The Scheme's condition related to the Share Purchase has been satisfied, and Arix expects to publish the Shareholder circular later this week. Arix Bioscience PLC RTW Biotech Opportunities Ltd All-share Acquisition Resignation Of Directors Scheme Update
PRESS RELEASE published on 01/22/2024 at 08:00, 1 year 10 months ago Nordea Bank Abp: Repurchase of own shares on 19.01.2024 Nordea Bank Abp has completed the repurchase of its own shares on 19.01.2024 as part of a share buy-back program. The transactions were executed in public trading and in accordance with relevant regulations. After the disclosed transactions, Nordea holds treasury shares for capital optimisation and remuneration purposes. For further information, investors and media can contact the provided representatives. Investor Relations Treasury Shares Nordea Bank Abp Share Buy-back Program Stock Exchange
PRESS RELEASE published on 01/22/2024 at 07:34, 1 year 10 months ago Appointment of Vulcan Group Chief Financial Officer Vulcan Energy Resources Limited announces the appointment of Ms Felicity Gooding as the Group Chief Financial Officer, bringing over 20 years of extensive global CFO experience to the company. Her expertise in capital markets and project financing will be crucial in the financing of Vulcan's Zero Carbon Lithium™ Project. This strategic appointment reflects the company's growth and development stage. Additionally, Mr Robert Ierace will step down from his role as CFO-Australia. Vulcan Energy Resources Limited aims to decarbonize lithium production and contribute to the European EV supply chain with its Zero Carbon Lithium™ Project. CFO Appointment Vulcan Energy Resources Limited Felicity Gooding Zero Carbon Lithium™ Project European EV Supply Chain
PRESS RELEASE published on 01/22/2024 at 07:30, 1 year 10 months ago Evotec SE: Invitation to Conference Call Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links. Conference Call Business Update Evotec SE Corporate Governance Market Developments
Published on 12/20/2025 at 00:30, 1 day 22 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 18:30, 2 days 4 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 7 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 9 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/21/2025 at 08:55, 13 hours 42 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 5 hours ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 12 hours ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 2 days ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 2 days ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 21:57, 2 days ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 14 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 14 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 15 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 15 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION